Effect of infliximab therapy on lipid pattern in patients with psoriatic arthritis

被引：0
|
作者：
Rosu, A. [1 ]
Ciurea, P. [1 ]
Musetescu, A. [1 ]
Vreju, F. [1 ]
机构：
[1] Univ Med & Pharm, Cralova, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [41] Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
    Antoni, Christian E.
    Kavanaugh, Arthur
    van der Heijde, Desiree
    Beutler, Anna
    Keenan, Gregory
    Zhou, Bie
    Kirkham, Bruce
    Tutuncu, Zuhre
    Burmester, Gerd R.
    Schneider, Udo
    Furst, Daniel E.
    Molitor, Jerry
    Keystone, Edward
    Gladman, Dafna D.
    Manger, Bernhard
    Wassenberg, Siegfried
    Weier, Ralf
    Wallace, Daniel J.
    Weisman, Michael H.
    Kalden, Joachim R.
    Smolen, Josef S.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 869 - 876
  • [42] The cost-effectiveness of adding infliximab to usual therapy in the treatment of psoriatic arthritis
    Marra, CA
    Maetzel, A
    Farewell, VT
    Rashidi, AA
    Shi, P
    Antoni, C
    Wong, JB
    Gladman, DD
    VALUE IN HEALTH, 2005, 8 (03) : 242 - 242
  • [43] Infliximab improves signs of plaque psoriasis in patients with psoriatic arthritis.
    Menter, A
    Evans, R
    Dooley, LT
    Patel, K
    Guzzo, C
    Matheson, R
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S167 - S167
  • [44] The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Vergel, Y. Bravo
    Hawkins, N. S.
    Claxton, K.
    Asseburg, C.
    Palmer, S.
    Woolacott, N.
    Bruce, I. N.
    Sculpher, M. J.
    RHEUMATOLOGY, 2007, 46 (11) : 1729 - 1735
  • [45] The correlation of skin and joint response in patients with psoriatic arthritis treated with infliximab
    Krueger, GG
    Antoni, C
    Bala, M
    Yan, S
    Zhao, N
    Beutler, A
    Guzzo, C
    Kavanaugh, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 319 - +
  • [46] Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy
    Sakellariou, Grigorios T.
    Vounotrypidis, Periklis
    Berberidis, Charalampos
    CLINICAL RHEUMATOLOGY, 2007, 26 (07) : 1132 - 1133
  • [47] The cost-effectiveness of adding infliximab to usual therapy in the treatment of psoriatic arthritis
    Marra, CA
    Farewell, V
    Antoni, C
    Rashidi, A
    Maetzel, A
    Kavanaugh, A
    Mease, P
    Wong, JB
    Gladman, DD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 333 - 333
  • [48] Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis
    Dafna D Gladman
    Nature Clinical Practice Rheumatology, 2008, 4 : 510 - 511
  • [49] Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy
    Grigorios T. Sakellariou
    Periklis Vounotrypidis
    Charalampos Berberidis
    Clinical Rheumatology, 2007, 26 : 1132 - 1133
  • [50] Use of infliximab to treat psoriatic arthritis in HIV-positive patients
    Sellam, Jeremie
    Bouvard, Beatrice
    Masson, Charles
    Rousiere, Mickael
    Villoutreix, Caroline
    Lacombe, Karine
    Khanine, Vanessa
    Chennebault, Jean-Marie
    Leclech, Christian
    Audran, Maurice
    Berenbaum, Francis
    JOINT BONE SPINE, 2007, 74 (02) : 197 - 200
12345